Drug Digest: Developments in Small Molecule APIs, Excipients, and Ingredients

In this exclusive Drug Digest video, experts discuss the state of the small molecule market amid challenges such as novel excipients, supply chain concerns, regulatory hurdles, artificial intelligence integration, and reliance on sustainable practices, with a look into the future at what’s next for this area of drug discovery.

Register Free: https://www.pharmtech.com/pt_w/apis

Event Overview:

Small molecule discovery has taken a lead role in some of 2025’s most prominent drug development storylines, such as the persistent popularity of GLP-1s. This episode of Drug Digest identifies the unique challenges of novel excipients, supply chain concerns, regulatory hurdles, artificial intelligence integration, and increases in sustainable practices, as developers continue to find new avenues to innovation.
Interviews featuring:

• Recipharm [KOL TBD]
• SK pharmteco [KOL TBD]
• Possibly one more company
• Dave Miller, PhD, Chief Scientific Officer, AustinPx (repurposed from video already on PharmTech site)

Key Learning Objectives:

• What the current state of the small molecule market is
• The main challenges facing those working on small-molecule drug discovery
• How CDMOs can leverage their expertise
• Hurdles of regulatory requirements, AI, supply chain disruptions, and sustainable practices

Who Should Attend:

• CDMOs
• Formulation scientists
• Development scientists
• Researchers or innovators with a focus in small molecules

Speaker:

TBD

Register Free: https://www.pharmtech.com/pt_w/apis